Bhubaneswar: Odisha’s State Level Single Window Clearance Authority (SLSWCA) on Tuesday approved 31 projects worth around Rs ...

During the 131st SLSWCA meeting held under chairmanship of Chief Secretary Manoj Ahuja, the investment plans across various ...

During a Case-Based Roundtable® event,  Michael R. Bishop, MD, moderated a discussion on monitoring and treatment of chronic ...

Committee for Medicinal Products for Human Use (CHMP) has recommended approving AstraZeneca’s Fasenra (benralizumab) to treat ...

Findings from the phase 3 SIERRA study showed that Iomab-B was associated with a higher durable complete response rate vs ...

Ketamine treatment among patients with fibromyalgia may offer short-term pain relief, though its long-term efficacy and safety remain uncertain.

Nevro noted that it expects to launch its full market release of HFX iQ with HFX AdaptivAI in the U.S. in the fourth quarter of 2024. For more information on HFX AdaptivAI, please visit ...

The primary goals of the study are to evaluate the safety and overall response rate in patients who are given RLS-0071.

For patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor ...

Multiple myeloma (MM) is a type of blood cancer that typically has no cure. Treatments like medications and stem cell ...

With FDA approval for imetelstat and solid financials, Geron shows great promise in MDS treatment. Read more on GERN stock ...

For patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor ...